384 related articles for article (PubMed ID: 2233931)
1. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation.
; Singer DE; Hughes RA; Gress DR; Sheehan MA; Oertel LB; Maraventano SW; Blewett DR; Rosner B; Kistler JP
N Engl J Med; 1990 Nov; 323(22):1505-11. PubMed ID: 2233931
[TBL] [Abstract][Full Text] [Related]
2. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.
Ezekowitz MD; Bridgers SL; James KE; Carliner NH; Colling CL; Gornick CC; Krause-Steinrauf H; Kurtzke JF; Nazarian SM; Radford MJ
N Engl J Med; 1992 Nov; 327(20):1406-12. PubMed ID: 1406859
[TBL] [Abstract][Full Text] [Related]
3. Stroke Prevention in Atrial Fibrillation Study. Final results.
Circulation; 1991 Aug; 84(2):527-39. PubMed ID: 1860198
[TBL] [Abstract][Full Text] [Related]
4. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
[TBL] [Abstract][Full Text] [Related]
5. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study.
Stroke Prevention in Atrial Fibrillation Study Group Investigators
N Engl J Med; 1990 Mar; 322(12):863-8. PubMed ID: 2407959
[TBL] [Abstract][Full Text] [Related]
6. The effect of aspirin on the risk of stroke in patients with nonrheumatic atrial fibrillation: The BAATAF Study.
Singer DE; Hughes RA; Gress DR; Sheehan MA; Oertel LB; Maraventano SW; Blewett DR; Rosner B; Kistler JP
Am Heart J; 1992 Dec; 124(6):1567-73. PubMed ID: 1462916
[TBL] [Abstract][Full Text] [Related]
7. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.
Hylek EM; Skates SJ; Sheehan MA; Singer DE
N Engl J Med; 1996 Aug; 335(8):540-6. PubMed ID: 8678931
[TBL] [Abstract][Full Text] [Related]
8. Preventing stroke in patients with nonrheumatic atrial fibrillation.
Nelson KM; Talbert RL
Am J Hosp Pharm; 1994 May; 51(9):1175-83. PubMed ID: 8042636
[TBL] [Abstract][Full Text] [Related]
9. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
[TBL] [Abstract][Full Text] [Related]
10. Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study.
Gulløv AL; Koefoed BG; Petersen P; Pedersen TS; Andersen ED; Godtfredsen J; Boysen G
Arch Intern Med; 1998 Jul; 158(14):1513-21. PubMed ID: 9679792
[TBL] [Abstract][Full Text] [Related]
11. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.
Lancet; 1994 Mar; 343(8899):687-91. PubMed ID: 7907677
[TBL] [Abstract][Full Text] [Related]
12. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial.
Lancet; 1996 Sep; 348(9028):633-8. PubMed ID: 8782752
[TBL] [Abstract][Full Text] [Related]
13. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48.
Giugliano RP; Ruff CT; Rost NS; Silverman S; Wiviott SD; Lowe C; Deenadayalu N; Murphy SA; Grip LT; Betcher JM; Duggal A; Dave J; Shi M; Mercuri M; Antman EM; Braunwald E;
Stroke; 2014 Aug; 45(8):2372-8. PubMed ID: 24947287
[TBL] [Abstract][Full Text] [Related]
14. [The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin].
Hu DY; Zhang HP; Sun YH; Jiang LQ;
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):295-8. PubMed ID: 16776915
[TBL] [Abstract][Full Text] [Related]
15. [Atrial fibrillation and apoplexy--risks and prevention].
Koefoed BG; Gulløv AL; Petersen P
Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641
[TBL] [Abstract][Full Text] [Related]
16. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation.
Pengo V; Zasso A; Barbero F; Banzato A; Nante G; Parissenti L; John N; Noventa F; Dalla Volta S
Am J Cardiol; 1998 Aug; 82(4):433-7. PubMed ID: 9723629
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant therapy for atrial fibrillation. Recommendations from major studies.
Kahn JK
Postgrad Med; 1992 Sep; 92(3):119-24, 129-30. PubMed ID: 1518749
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation.
Gage BF; Cardinalli AB; Albers GW; Owens DK
JAMA; 1995 Dec; 274(23):1839-45. PubMed ID: 7500532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]